津普森 |
B901101-100mg |
100mg |
现货 |
915019-65-7 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... |
98+%,B |
547.90
547.90
|
|
津普森 |
B901101-10mg |
10mg |
现货 |
915019-65-7 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... |
98+%,B |
118.00
118.00
|
|
津普森 |
B901101-50mg |
50mg |
现货 |
915019-65-7 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... |
98+%,B |
348.50
348.50
|
|
罗恩 |
R031394-25mg |
25mg |
5~7个工作日 |
915019-65-7 |
2-甲基-2-[4-[3-甲基-2-氧代-8-(喹啉-3... 2-methyl-2-[4-(3-methyl-2-ox... |
99% |
333.00
333.00
|
|
罗恩 |
R031394-100mg |
100mg |
5~7个工作日 |
915019-65-7 |
2-甲基-2-[4-[3-甲基-2-氧代-8-(喹啉-3... 2-methyl-2-[4-(3-methyl-2-ox... |
99% |
1,001.00
1,001.00
|
|
Selleck |
S1009100mg |
100mg |
现货 |
915019-65-7 |
Dactolisib (BEZ235, NVP-BEZ2... |
|
1,414.41
1,414.41
|
|
Selleck |
S100950mg |
50mg |
现货 |
915019-65-7 |
Dactolisib (BEZ235, NVP-BEZ2... |
|
895.88
895.88
|
|
毕得 |
BD157891-50mg |
50mg |
现货 |
915019-65-7 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-Methyl-2-(4-(3-methyl-2-ox... |
98+% |
505.00
505.00
|
|
毕得 |
BD157891-100mg |
100mg |
现货 |
915019-65-7 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-Methyl-2-(4-(3-methyl-2-ox... |
98+% |
794.00
794.00
|
|
毕得 |
BD157891-10mg |
10mg |
现货 |
915019-65-7 |
2-甲基-2-(4-(3-甲基-2-氧代-8-(喹啉-3... 2-Methyl-2-(4-(3-methyl-2-ox... |
98+% |
149.00
149.00
|
|
阿拉丁 |
B126286-25mg |
25mg |
现货 |
915019-65-7 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
277.90
277.90
|
|
阿拉丁 |
B126286-100mg |
100mg |
现货 |
915019-65-7 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
833.90
833.90
|
|
阿拉丁 |
B126286-1g |
1g |
期货,请咨询 |
915019-65-7 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
2,879.90
2,879.90
|
|
阿拉丁 |
B126286-250mg |
250mg |
期货,请咨询 |
915019-65-7 |
BEZ235,有效的PI3K和mTOR抑制剂 BEZ235 |
Moligand™, ≥99% |
1,062.90
1,062.90
|
|
麦克林 |
N855207-1g |
1g |
现货 |
915019-65-7 |
NVP-BEZ235 NVP-BEZ235 |
98% |
2,720.00
2,720.00
|
|
麦克林 |
N855207-250mg |
250mg |
现货 |
915019-65-7 |
NVP-BEZ235 NVP-BEZ235 |
98% |
917.00
917.00
|
|